^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
Source:
Title:

TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo

Published date:
12/28/2015
Excerpt:
These findings suggest that TM4SF1 is a surface membrane antigen that is highly expressed in pancreatic cancer cells and increases the chemoresistance to gemcitabine.
DOI:
10.1371/journal.pone.0144969